Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis

Multiple Sclerosis Journal

Volumn 20, Issue 3, 2014, Pages 322-330

  Papadopoulou, Athina ^a,b   Menegola, Milena ^a   Kuhle, Jens ^a   Ramagopalan, Sreeram V ^c,d,e   D'Souza, Marcus ^a   Sprenger, Till ^a   Radue, Ernst Wilhelm ^b   Kappos, Ludwig ^a   Yaldizli, Özgür ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Medical Image Analysis Center   (Switzerland)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

black holes; lesion to ventricle distance; magnetic resonance imaging; Multiple sclerosis; subventricular zone

Indexed keywords

ADULT; ARTICLE; BRAIN LATERAL VENTRICLE; CONTRAST ENHANCEMENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RELAPSE; REMISSION; REMYELINIZATION; RISK FACTOR; SUBVENTRICULAR ZONE; ALLELE; BLACK HOLE; BLACK HOLE SIZE; BRAIN DISEASE; CORRELATIONAL STUDY; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; GENE; HLA DRB GENE; LESION TO VENTRICLE DISTANCE; MULTICENTER STUDY (TOPIC); NERVOUS SYSTEM PARAMETERS; PHASE 2 CLINICAL TRIAL (TOPIC); PREDICTION; PREDICTOR VARIABLE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; WHITE MATTER;

BLACK HOLES; LESION-TO-VENTRICLE DISTANCE; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; SUBVENTRICULAR ZONE;

ADULT; BRAIN; CEREBRAL VENTRICLES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NERVE FIBERS, MYELINATED; RISK FACTORS;

EID: 84895759783     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513495583     Document Type: Article

References (34)

1. van Waesberghe JH, van Walderveen MA, Castelijns JA, et al. Patterns of lesion development in multiple sclerosis: Longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR Am J Neuroradiol. 1998 ; 19: 675-683 (Pubitemid 30422711)
2. Bruck W, Bitsch A, Kolenda H, et al. Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol. 1997 ; 42: 783-793 (Pubitemid 27481551)
3. van Walderveen MA, Kamphorst W, Scheltens P, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology. 1998 ; 50: 1282-1288 (Pubitemid 28240340)
4. Barkhof F, Bruck W, De Groot CJ, et al. Remyelinated lesions in multiple sclerosis: Magnetic resonance image appearance. Arch Neurol. 2003 ; 60: 1073-1081 (Pubitemid 36975794)
5. Bitsch A, Kuhlmann T, Stadelmann C, et al. A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol. 2001 ; 49: 793-796 (Pubitemid 32530247)
6. Sahraian MA, Radue EW, Haller S, et al. Black holes in multiple sclerosis: Definition, evolution, and clinical correlations. Acta Neurol Scand. 2010 ; 122: 1-8
7. Kotter MR, Stadelmann C, Hartung HP. Enhancing remyelination in disease - can we wrap it up?. Brain. 2011 ; 134: 1882-1900
8. Nait-Oumesmar B, Picard-Riera N, Kerninon C, et al. The role of SVZ-derived neural precursors in demyelinating diseases: From animal models to multiple sclerosis. J Neurol Sci. 2008 ; 265: 26-31
9. Nait-Oumesmar B, Decker L, Lachapelle F, et al. Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination. Eur J Neurosci. 1999 ; 11: 4357-4366 (Pubitemid 30009267)
10. Picard-Riera N, Decker L, Delarasse C, et al. Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice. Proc Natl Acad Sci U S A. 2002 ; 99: 13211-13216
11. Nait-Oumesmar B, Picard-Riera N, Kerninon C, et al. Activation of the subventricular zone in multiple sclerosis: Evidence for early glial progenitors. Proc Natl Acad Sci U S A. 2007 ; 104: 4694-4699 (Pubitemid 47186287)
12. Garren H, Robinson WH, Krasulova E, et al. Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis. Ann Neurol. 2008 ; 63: 611-620
13. Turner B, Ramli N, Blumhardt LD, et al. Ventricular enlargement in multiple sclerosis: A comparison of three-dimensional and linear MRI estimates. Neuroradiology. 2001 ; 43: 608-614 (Pubitemid 32755680)
14. Karampekios S, Papanikolaou N, Papadaki E, et al. Quantification of magnetization transfer rate and native T1 relaxation time of the brain: Correlation with magnetization transfer ratio measurements in patients with multiple sclerosis. Neuroradiology. 2005 ; 47: 189-196 (Pubitemid 40778824)
15. Levesque I, Sled JG, Narayanan S, et al. The role of edema and demyelination in chronic T1 black holes: A quantitative magnetization transfer study. J Magn Reson Imaging. 2005 ; 21: 103-110
16. Patrikios P, Stadelmann C, Kutzelnigg A, et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain. 2006 ; 129: 3165-3172 (Pubitemid 44871433)
17. Menard A, Pierig R, Pelletier J, et al. Detection of a gliotoxic activity in the cerebrospinal fluid from multiple sclerosis patients. Neurosci Lett. 1998 ; 245: 49-52 (Pubitemid 28241613)
18. Cid C, Alcázar A, Regidor I, et al. Neuronal apoptosis induced by cerebrospinal fluid from multiple sclerosis patients correlates with hypointense lesions on T1 magnetic resonance imaging. J Neurol Sci. 2002 ; 193: 103-109 (Pubitemid 34098941)
19. Chang A, Tourtellotte WW, Rudick R, et al. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med. 2002 ; 346: 165-173 (Pubitemid 34438882)
20. John GR, Shankar SL, Shafit-Zagardo B, et al. Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med. 2002 ; 8: 1115-1121 (Pubitemid 35175966)
21. Kuhlmann T, Miron V, Cui Q, et al. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain. 2008 ; 131: 1749-1758 (Pubitemid 351957453)
22. Charles P, Reynolds R, Seilhean D, et al. Re-expression of PSA-NCAM by demyelinated axons: An inhibitor of remyelination in multiple sclerosis?. Brain. 2002 ; 125: 1972-1979
23. Rovira A, Alonso J, Cucurella G, et al. Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images. AJNR Am J Neuroradiol. 1999 ; 20: 1939-1945
24. Zhang Y, Traboulsee A, Zhao Y, et al. Texture analysis differentiates persistent and transient T1 black holes at acute onset in multiple sclerosis: A preliminary study. Mult Scler. 2011 ; 17: 532-540
25. van Walderveen MA, Lycklama ANG, Ader HJ, et al. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: Relation to clinical characteristics in subgroups of patients with multiple sclerosis. Arch Neurol. 2001 ; 58: 76-81 (Pubitemid 32053210)
26. van Walderveen MA, Truyen L, van Oosten BW, et al. Development of hypointense lesions on T1-weighted spin-echo magnetic resonance images in multiple sclerosis: Relation to inflammatory activity. Arch Neurol. 1999 ; 56: 345-351 (Pubitemid 29120233)
27. Enzinger C, Ropele S, Smith S, et al. Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-epsilon 4. Ann Neurol. 2004 ; 55: 563-569 (Pubitemid 38391974)
28. Minneboo A, Uitdehaag BM, Jongen P, et al. Association between MRI parameters and the MS severity scale: A 12 year follow-up study. Mult Scler. 2009 ; 15: 632-637
29. van Walderveen MA, Barkhof F, Hommes OR, et al. Correlating MRI and clinical disease activity in multiple sclerosis: Relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images. Neurology. 1995 ; 45: 1684-1690
30. Zivadinov R, Uxa L, Bratina A, et al. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis. Int Rev Neurobiol. 2007 ; 79: 521-535
31. Ciccarelli O, Giugni E, Paolillo A, et al. Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosis. Eur J Neurol. 1999 ; 6: 455-459 (Pubitemid 29371143)
32. Li BS, Regal J, Soher BJ, et al. Brain metabolite profiles of T1-hypointense lesions in relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol. 2003 ; 24: 68-74 (Pubitemid 36110103)
33. Bagnato F, Ikonomidou VN, van Gelderen P, et al. Lesions by tissue specific imaging characterize multiple sclerosis patients with more advanced disease. Mult Scler. 2011 ; 17: 1424-1431
34. Vavasour IM, Li DK, Laule C, et al. Multi-parametric MR assessment of T(1) black holes in multiple sclerosis: Evidence that myelin loss is not greater in hypointense versus isointense T(1) lesions. J Neurol. 2007 ; 254: 1653-1659